Biopolymer nanoparticle production for controlled release of biopharmaceuticals

Critical Reviews in Biotechnology

Volumn 34, Issue 2, 2014, Pages 161-179

  Hudson, David ^a   Margaritis, Argyrios ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Albumin; Alginate; Chitosan; Complexation; Desolvation; Emulsification; Encapsulation; Gelatin; Ionic gelation; Pullulan

Indexed keywords

ALGINATE; CHITOSAN; COMPLEXATION; DRUG DELIVERY; EMULSIFICATION; ENCAPSULATION; GELATION; MICROEMULSIONS; NANOPARTICLES; NATURAL POLYMERS;

ALBUMIN; DESOLVATION; GELATIN; IONIC GELATIONS; PULLULANS;

BIOMOLECULES;

ALBUMIN; ALGINIC ACID; CHITOSAN; DEXTRAN; GELATIN; GLIADIN; PULLULAN; BIOPOLYMER; DELAYED RELEASE FORMULATION; NANOPARTICLE;

ARTICLE; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; CROSS LINKING; GELATION; MICELLE; MICROEMULSION; NANOENCAPSULATION; PH; PRIORITY JOURNAL; DELAYED RELEASE FORMULATION; MEDICINAL CHEMISTRY;

BIOPOLYMERS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; NANOPARTICLES;

EID: 84901797899     PISSN: 07388551     EISSN: 15497801     Source Type: Journal    
DOI: 10.3109/07388551.2012.743503     Document Type: Article

References (125)

1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. 2004. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100: 5-28. (Pubitemid 39445982)
2. Ahmad Z, Sharma S, Khuller GK. 2007. Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis. Nanomedicine 3: 239-243. (Pubitemid 47332342)
3. Akagi T, Kaneko T, Kida T, Akashi M. 2005. Preparation and characterization of biodegradable nanoparticles based on poly(gglutamic acid) with l-phenylalanine as a protein carrier. J Control Release 108: 226-236. (Pubitemid 41608656)
4. Akagi T, Kaneko T, Kida T, Akashi M. 2006. Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(γ- glutamic acid). J Biomater Sci Polym Ed 17: 875-892.
5. Akiyoshi K, Deguchi S, Moriguchi N, Yamaguchi S, Sunamoto J. 1993. Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules 26: 3062-3068. (Pubitemid 23692851)
6. Anto Shering M, Kannan C, Sabari Kumar K, Sathish Kumar V, Suganeshwari M. 2011. Formulation of 5-fluorouracil loaded chitosan nanoparticles by emulsion droplet coalescence method for cancer therapy. Int J Pharm Bio Arc 2, 926-931.
7. Bajaj IB; Singhal RS. 2010. Effect of aeration and agitation on synthesis of poly (γ-glutamic acid) in batch cultures of Bacillus licheniformis NCIM 2324. Biotechnology and Bioprocess Engineering 15, 635-640.
8. Bajpai AK, Choubey J. 2006. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci Mater Med 17: 345-358.
9. Barratt GM. 2000. Therapeutic applications of colloidal drug carriers. Pharm Sci Technol Today 3: 163-171. (Pubitemid 30261519)
10. Bodmeier R, Oh K, Pramar Y. 1989. Preparation and evaluation of drugcontaining chitosan beads. Drug Dev Ind Pharm 15: 1475-1494.
11. Bokharaei M, Margaritis A, Xenocostas A, Freeman DJ. 2011. Erythropoietin encapsulation in chitosan nanoparticles and kinetics of drug release. Curr Drug Deliv 8: 164-171.
12. Bulmer C, Margaritis A, Xenocostas A. 2012a. Production and characterization of novel chitosan nanoparticles for controlled release of rHu-erythropoietin. Biochem Eng J 68: 61-69.
13. Bulmer C, Margaritis A, Xenocostas A. 2012b. Encapsulation and controlled release of recombinant human erythropoietin from chitosan-carrageenan nanoparticles. Curr Drug Deliv 9: 527-537.
14. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. 1997. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Poly Sci 63: 125-132. (Pubitemid 127613982)
15. Calvo P, Vila-Jato JL, Alonso MJ. 1997. Evaluation of cationic polymercoated nanocapsules as ocular drug carriers. Int J Pharm 153: 41-50. (Pubitemid 27283332)
16. Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY. 1989. Three-dimensional structure of human serum albumin. Science 244: 1195-1198. (Pubitemid 19170494)
17. Cascone MG, Lazzeri L, Carmignani C, Zhu Z. 2002. Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J Mater Sci Mater Med 13: 523-526. (Pubitemid 34454486)
18. Chakravarthi SS, Robinson DH. 2008. Biodegradable nanoparticles. In: Gads SC, ed. Pharmaceutical Manufacturing Handbook. Haboken: John Wiley & Sons, 535-565.
19. Chen M, Liu L, Liu Y, Yang W, Li X, Li R, Zhou Z, Wang Y, Zhang Q. 2011. Preparation and characterization of self-assembled nanoparticles of 6- O-cholesterol-modified chitosan for drug delivery. Carbohydr Polym 84: 1244-1251.
20. Cheng KC, Demirci A, Catchmark JM. 2011. Pullulan: biosynthesis, production, and applications. Appl Microbiol Biotechnol 92: 29-44.
21. Cho CS, Jeong YI, Ishihara T, Takei R, Park JU, Park KH, Maruyama A, Akaike T. 1997. Simple preparation of nanoparticles coated with carbohydrate-carrying polymers. Biomaterials 18: 323-326. (Pubitemid 27073053)
22. Cho CS, Kobayashi A, Takei R, Ishihara T, Maruyama A, Akaike T. 2001. Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Biomaterials 22: 45-51.
23. Chuang C, Don T, Chiu W. 2009. Synthesis of chitosan-based thermoand pH-responsive porous nanoparticles by temperature-dependent self-assembly method and their application in drug release. J Polym Sci Part A: Polym Chem 47: 5126-5136.
24. Coester CJ, Langer K, van Briesen H, Kreuter J. 2000. Gelatin nanoparticles by two step desolvation-a new preparation method, surface modifications and cell uptake. J Microencapsul 17: 187-193. (Pubitemid 30135796)
25. Cohn EJ, Strong LE. 1946. Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 68: 459-475.
26. Courts A. 1954. The N-terminal amino acid residues of gelatin. 1. Intact gelatins. Biochem J 58: 70-74.
27. Cromwick AM, Birrer GA, Gross RA. 1996. Effects of pH and aeration on γ-poly(glutamic acid) formation by Bacillus licheniformis in controlled batch fermentor cultures. Biotechnol Bioeng 50: 222-227. (Pubitemid 26095156)
28. Daly M, Knorr D. 1988. Chitosan-alginate complex coacervate capsules: effects of calcium chloride, plasticizers, and polyelectrolytes on mechanical stability. Biotechnol Progr 4: 76-81. (Pubitemid 18645221)
29. De Jong WH, Borm PJ. 2008. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3: 133-149. (Pubitemid 352042401)
30. Duclairoir C, Nakache E, Marchais H, Orecchioni A. (1998). Formation of gliadin nanoparticles: Influence of the solubility parameter of the protein solvent. Colloid Polym Sci 276: 321-327. (Pubitemid 28233984)
31. Duclairoir C, Orecchioni AM, Depraetere P, Osterstock F, Nakache E. 2003. Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs. Int J Pharm 253: 133-144. (Pubitemid 36197837)
32. El-Shabouri MH. 2002. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm 249: 101-108. (Pubitemid 35333436)
33. Elzoghby AO, Samy WM, Elgindy NA. 2012. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 157: 168-182.
34. Ezpeleta I, Irache JM, Stainmesse S, Chabenat C, Gueguen J, Popineau Y, Orecchioni A. (1996). Gliadin nanoparticles for the controlled release of all-trans-retinoic acid. Int J Pharm 131: 191-200.
35. Fakirov S. 2007. Gelatin and gelatin-based biodegradable composites: manufacturing, properties, and biodegradation behavior. In: Fakirov S, Bhattacharyya D, eds. Handbook of Engineering Biopolymers: Homopolymers, Blends, and Composites. Munich: Hanser, 419-464.
36. Farrugia CA, Groves MJ. 1999. Gelatin behaviour in dilute aqueous solution: designing a nanoparticulate formulation. J Pharm Pharmacol 51: 643-649. (Pubitemid 29346704)
37. Gaur U, Sahoo SK, De TK, Ghosh PC, Maitra A, Ghosh PK. 2000. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 202: 1-10. (Pubitemid 30466224)
38. Gianibelli MC, Larroque OR, MacRitchie F, Wrigley CW. (2001a). Biochemical, genetic, and molecular characterization of wheat glutenin and its component subunits. Cereal Chem 78, 635-646. (Pubitemid 33050994)
39. Gianibelli MC, Larroque OR, Macritchie F, Wrigley CW. (2001b). Biochemical, genetic, and molecular characterization of wheat endosperm proteins. Cereal Chem 78, 635-646. (Pubitemid 33050994)
40. Goncalves VL, Laranjeira MCM, Fávere VT, Pedrosa RC. (2005). Effect of crosslinking agents on chitosan microspheres in controlled release of diclofenac sodium. Polímeros 15: 6-12.
41. Gupta M, Gupta AK. 2004a. Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. J Control Release 99: 157-166. (Pubitemid 39165741)
42. Gupta M, Gupta AK. 2004b. In vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by AOT/N-hexane micellar system. J Pharm Pharm Sci 7: 38-46. (Pubitemid 38628935)
43. Haug A. 1964. Composition and properties of alginates. Composition and properties of alginates (Thesis). Trondheim: Norwegian Institute of Technology.
44. Heinze T, Liebert T, Heublein B, Hornig S. 2006. Functional polymers based on dextran. Berlin: Springer.
45. Higashi N, Shosu T, Koga T, Niwa M, Tanigawa T. 2006. pH-responsive, self-assembling nanoparticle from a fullerene-tagged poly(L-glutamic acid) and its superoxide dismutase mimetic property. J Colloid Interface Sci 298: 118-123. (Pubitemid 44294383)
46. Hitzman CJ, Wattenberg LW, Wiedmann TS. 2006. Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipidcoated nanoparticles. J Pharm Sci 95: 1196-1211. (Pubitemid 43874436)
47. Hu Y, Jiang X, Ding Y, Ge H, Yuan Y, Yang C. 2002. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials 23: 3193-3201. (Pubitemid 34525103)
48. Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA. 2002. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8: 1038-1044. (Pubitemid 34517637)
49. Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS. 2005. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 296: 151-161. (Pubitemid 40693384)
50. Jones RT. 2004. Gelatin: Manufacture and physio-chemical properties. In: Podczeck F, Jones B, eds. Pharmaceutical Capsules. London: Pharmaceutical Press, 23-39.
51. Karthikeyan RS, Rakshit SK, Baradarajan A. 1996. Optimization of batch fermentation conditions for dextran production. Biopro Eng 15: 247-251.
52. Kim IS, Oh IJ. 2010. Preparation and characterization of stearic acidpullulan nanoparticles. Arch Pharm Res 33: 761-767.
53. Koizumi F, Kitagawa M, Negishi T, Onda T, Matsumoto S, Hamaguchi T, Matsumura Y. 2006. Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res 66: 10048-10056. (Pubitemid 44672058)
54. Kratz F. 2008. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132: 171-183.
55. Krause HJ, Rohdewald P. 1985. Preparation of gelatin nanocapsules and their pharmaceutical characterization. Pharm Res 2: 239-243. (Pubitemid 15228742)
56. Kumari A, Yadav SK, Yadav SC. 2010. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75: 1-18.
57. Kuriyel R, Fushijima M, Jung GW. 2009. Advancements in membrane processes for pharmaceutical applications. In: Pabby AK, Rizvi SS, Sastre AM, eds. Handbook of Membrane Separations: Chemical, Pharmaceutical, Food and Biotechnological Applications. Boca Raton: CRC Press, 415-424.
58. Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. 2003. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 257: 169-180. (Pubitemid 36507043)
59. Leathers TD. 2005. Dextran. In: Steinbüchel A, ed. Polysaccharides and polyamides in the food industry: properties, production, and patents volume 1. Weinheim: Wiley-VCH, 233-257.
60. Lee KY, Mooney DJ. 2012. Alginate: properties and biomedical applications. Prog Polym Sci 37: 106-126.
61. Leong YS, Candau F. 1982. Inverse microemulsion polymerization. J Phys Chem 86: 2269-2271.
62. Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT. 1998. DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release 53: 183-193. (Pubitemid 28218701)
63. Li JK, Wang N, Wu XS. 1998. Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method. J Microencapsul 15: 163-172. (Pubitemid 28105132)
64. Lin W, Coombes AG, Davies MC, Davis SS, Illum L. 1993. Preparation of sub-100 nm human serum albumin nanospheres using a pHcoacervation method. J Drug Target 1: 237-243.
65. Lin W, Coombes AG, Garnett MC, Davies MC, Schacht E, Davis SS, Illum L. 1994. Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent. Pharm Res 11: 1588-1592. (Pubitemid 24339679)
66. Lin W, Garnett MC, Davies MC, Bignotti F, Ferruti P, Davis SS, Illum L. 1997. Preparation of surface-modified albumin nanospheres. Biomaterials 18: 559-565. (Pubitemid 27156270)
67. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. 2008. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60: 1650-1662.
68. Lochke AH, Rale VB. 1995. Trends in microbial production of pullulan and its novel applications in the food industry. In: Hui YH, Khachatourians GG, eds. Food Biotechnology: Microorganisms. New Jersey: Wiley-IEEE, 589-609.
69. López-León T, Carvalho EL, Seijo B, Ortega-Vinuesa JL, Bastos-González D. 2005. Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J Colloid Interface Sci 283: 344-351. (Pubitemid 40254961)
70. Maitra AN, Ghosh PK, De TK, Sahoo S. 1999. Process for the preparation of highly monodisperse polymeric hydrophilic nanoparticles. US Patent No. 587411.
71. Manocha B, Margaritis A. 2008. Production and characterization of γ-polyglutamic acid nanoparticles for controlled anticancer drug release. Crit Rev Biotechnol 28: 83-99. (Pubitemid 351882870)
72. Marty JJ, Oppenheim RC, Speiser P. 1978. Nanoparticles-a new colloidal drug delivery system. Pharm Acta Helv 53: 17-23.
73. Masotti A, Ortaggi G. 2009. Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery. Mini Rev Med Chem 9: 463-469.
74. Matejtschuk P, Dash CH, Gascoigne EW. 2000. Production of human albumin solution: a continually developing colloid. Br J Anaesth 85: 887-895.
75. Mehravar R, Jahanshahi M, Saghatoleslami N. (2009). Fabrication and evaluation of human serum albumin (HSA) nanoparticles for drug delivery application. Int J Nanosci 8, 319-322.
76. Mishra V, Mahor S, Rawat A, Gupta PN, Dubey P, Khatri K, Vyas SP. 2006. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target 14: 45-53.
77. Mitra S, Gaur U, Ghosh PC, Maitra AN. 2001. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74: 317-323. (Pubitemid 32727639)
78. Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. 2008. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 68: 513-525. (Pubitemid 351318222)
79. Munshi N, Chakarvorty K, De TK, Maitra AN. 1995. Activity and stability studies of ultrafine nanoencapsulated catalase and penicillinase. Colloid Polym Sci 273: 464-472.
80. Na K, Bae YH. 2002. Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro. Pharm Res 19: 681-688. (Pubitemid 34553678)
81. Na K, Lee ES, Bae YH. 2003. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pHdependent cell interaction, internalization and cytotoxicity in vitro. J Control Release 87: 3-13. (Pubitemid 36255443)
82. Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. 1993. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control Release 25: 89-98. (Pubitemid 23168633)
83. Nouvel C, Raynaud J, Marie E, Dellacherie E, Six JL, Durand A. 2009. Biodegradable nanoparticles made from polylactide-grafted dextran copolymers. J Colloid Interface Sci 330: 337-343.
84. Nussinovitch A. 1997. Hydrocolloid applications: gum technology in the food and other industries. London: Blackie Academic & Professional.
85. Oppenheim RC, Marty JJ, Speiser P. (1978). Injectable compositions, nanoparticles useful therein and process of manufacturing same. US Patent 4107288.
86. Oppenheim RC, Stewart NF. (1979). The manufacture and tumour cell uptake of nanoparticles labelled with fluorescein isothiocyanate. Drug Dev Ind Pharm 5: 563-571.
87. Patil GV. 2003. Biopolymer albumin for diagnosis and in drug delivery. Drug Develop Res 58: 219-247. (Pubitemid 36555058)
88. Peniche H, Peniche C. 2011. Chitosan nanoparticles: a contribution to nanomedicine. Polym Int 60: 883-889.
89. Poncelet D. 2001. Production of alginate beads by emulsification/internal gelation. Ann NY Acad Sci 944: 74-82. (Pubitemid 34053298)
90. Quong D, Neufeld RJ, Skja°k-Braek G, Poncelet D. 1998. External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation. Biotechnol Bioeng 57: 438-446. (Pubitemid 28051552)
91. Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. 2006. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2: 8-21.
92. Reis CP, Neufeld RJ, Vilela S, Ribeiro AJ, Veiga F. 2006. Review and current status of emulsion/dispersion technology using an internal gelation process for the design of alginate particles. J Microencapsul 23: 245-257. (Pubitemid 43977077)
93. Richard A, Margaritis A. 2001. Poly(glutamic acid) for biomedical applications. Crit Rev Biotechnol 21: 219-232. (Pubitemid 34074770)
94. Sæther HV, Holme HK, Maurstad G, Smidsrød O, Stokke BT. 2008. Polyelectrolyte complex formation using alginate and chitosan. Carbohydr Polym 74: 813-821.
95. Sarmento B, Ferreira D, Veiga F, Ribeiro A. 2006. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pregelation through DSC and FTIR studies. Carbohydr Polym 66: 1-7. (Pubitemid 44376662)
96. Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. 2007. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 24: 2198-2206. (Pubitemid 350060707)
97. Singh R, Lillard Jr JW. 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86: 215-223.
98. Sivabalan M, Anto Shering M, Reddy P, Vasudevaiah AJ, Nigila G. 2011. Formulation and evaluation of 5-fluoruracil loaded chitosan and eudragit nanoparticles for cancer therapy. Pharmacie Globa: Int J Compr Pharm 2: 1-4.
99. Stinchcombe TE. 2007. Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel. Nanomedicine (Lond) 2: 415-423. (Pubitemid 47365124)
100. Sundar S, Kundu J, Kundu SC. 2010. Biopolymeric nanoparticles Sci Tech Adv Mat 11: 014104.
101. Synowiecki J, Al-Khateeb NA. 2003. Production, properties, and some new applications of chitin and its derivatives. Crit Rev Food Sci Nutr 43: 145-171. (Pubitemid 38552306)
102. Tabata Y, Ikada Y. 1989. Synthesis of gelatin microspheres containing interferon. Pharm Res 6: 422-427. (Pubitemid 19176088)
103. Tahara K, Yamamoto H, Takeuchi H, Kawashima Y. 2007. Development of gene delivery system using PLGA nanospheres. Yakugaku Zasshi 127: 1541-1548. (Pubitemid 47511065)
104. Tang M, Dou H, Sun K. 2006. One-step synthesis of dextran-based stable nanoparticles assisted by self-assembly. Polymer 47: 728-734. (Pubitemid 43053275)
105. Tang ES, Huang M, Lim LY. 2003. Ultrasonication of chitosan and chitosan nanoparticles. Int J Pharm 265: 103-114. (Pubitemid 37176951)
106. Thewissen BG, Celus I, Brijs K, Delcour JA. 2011. Foaming properties of wheat gliadin. J Agric Food Chem 59: 1370-1375.
107. Tiyaboonchai W, Woiszwillo J, Middaugh CR. 2001. Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles. J Pharm Sci 90: 902-914. (Pubitemid 32645947)
108. Tiyaboonchai W, Woiszwillo J, Sims RC, Middaugh CR. 2003. Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int J Pharm 255: 139-151. (Pubitemid 36369598)
109. Tokumitsu H, Ichikawa H, Fukumori Y. 1999a. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm Res 16: 1830-1835. (Pubitemid 30040698)
110. Tokumitsu H, Ichikawa H, Fukumori Y, Block LH. 1999b. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Chem Pharm Bull 47: 838-842. (Pubitemid 29315373)
111. Toshio Y, Mitsuru H, Shozo M, Hitoshi S. 1981. Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and microspherical carriers of gelatin. Int J Pharm 8: 131-141.
112. Totre J, Ickowicz D, Domb A. 2011. Properties and hemostratic application of gelation. In: Domb A, Kumar N, Ezra A, eds. Biodegradable Polymers in Clinical Use and Clinical Development. Hoboken: John Wiley and Sons Inc., 92-106.
113. Tsai ML, Bai SW, Chen RH. 2008. Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticle. Carbohydr Polym 71: 448-457. (Pubitemid 350181062)
114. Vauchel P, Le Roux K, Leroux K, Kaas R, Arhaliass A, Baron R, Legrand J. 2009. Kinetics modeling of alginate alkaline extraction from Laminaria digitata. Bioresour Technol 100: 1291-1296.
115. Villemson AL, Couvreur P, Gref R, Larionova NI. 2007. Amphiphilic derivatives of dextran and related nanoparticles. Polym Sci Ser A 49: 708-715. (Pubitemid 47150958)
116. Wang Y, Liu L, Jiang Q, Zhang Q. 2007. Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin. Eur Polym J 43: 43-51. (Pubitemid 44894416)
117. Weber C, Kreuter J, Langer K. 2000. Desolvation process and surface characteristics of HSA-nanoparticles. Int J Pharm 196: 197-200. (Pubitemid 30105742)
118. Xu R, Fisher M, Juliano RL. 2011. Targeted albumin-based nanoparticles for delivery of amphipathic drugs. Bioconjug Chem 22: 870-878.
119. Yang L, Cui F, Cun D, Tao A, Shi K, Lin W. 2007. Preparation, characterization and biodistribution of the lactone form of 10- hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Int J Pharm 340: 163-172. (Pubitemid 47043353)
120. Yeh MK, Cheng KM, Hu CS, Huang YC, Young JJ. 2011. Novel proteinloaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization. Acta Biomater 7: 3804-3812.
121. Yoshioka T, Hashida M, Muranishi S, Sezaki H. 1981. Specific delivery of mitomycin C to the liver, spleen and lung: nano- and microspherical carriers of gelatin. Int J Pharm 81: 131-141. (Pubitemid 11078174)
122. You JO, Liu YC, Peng CA. 2006. Efficient gene transfection using chitosan-alginate core-shell nanoparticles. Int J Nanomed 1: 173-180.
123. You J, Peng C. 2005. Calcium-alginate nanoparticles formed by reverse microemulsion as gene carriers. Macromol Symp 219: 147-153.
124. Yuan X, Yuan Y, Li H. 2006. Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohydr Polym 65: 337-345. (Pubitemid 44160627)
125. Zhang HZ, Li XM, Gao FP, Liu LR, Zhou ZM, Zhang QQ. 2010. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery. Drug Deliv 17: 48-57.